Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (JANX)

CUSIP: 47103J105

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
-1,610,666
Put/Call ratio
12%
SEC-reported price per share
$10.73
Number of holders
64
Value change
-$17,204,195
Number of buys
40
Open additional details 1 more signal available
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,419,303

Security key

47103J105

Report period

Q4 2023

Institutions

64

Top holders

10

Ownership snapshot

Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bregua Corp
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $92,389,772 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $92.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
Bregua Corp $22.01M
RA CAPITAL MANAGEMENT, L.P. $92.39M
BVF INC/IL $46.16M
CITADEL ADVISORS LLC $34.59M
ORBIMED ADVISORS LLC $33.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bregua Corp
3/4/5
10%+ Owner
—
denominator unverified
$22,008,098
3,749,250 shares
— 15 Jun 2021
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$92,389,772
9,165,652 shares
— 30 Sep 2023
BVF INC/IL
13F
Company
13F
—
denominator unverified
$46,164,565
4,579,818 shares
— 30 Sep 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$34,586,587
3,431,209 shares
— 30 Sep 2023
ORBIMED ADVISORS LLC
13F 3/4/5
Company · Director
—
denominator unverified
$33,444,704
3,317,927 shares
— 30 Sep 2023
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$20,823,593
2,067,468 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
64
Shares
33,501,695
Rows available
64
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
57
Q4 2023 holders
64
Holder diff
7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .